CLARKSTON CAPITAL PARTNERS, LLC – Eli Lilly and Company Transaction History
CLARKSTON CAPITAL PARTNERS, LLC portfolio value:
$3.23M
portfolio value
CLARKSTON CAPITAL PARTNERS, LLC quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -8K | $323.35 | 10K | |
| Q2 2022 | share | Decrease | -0.99% | -100 shares | 350K | $324.23 | 10K |
| Q1 2022 | share | Increase | 0.00% | 10.1K shares | 2.89M | $286.37 | 10.1K |
| Q1 2017 | share | Decrease | -100.00% | -10K shares | -736K | $76 | 0 |
| Q4 2016 | share | 0.00% | 0 shares | -67K | $66.02 | 10K | |
| Q3 2016 | share | 0.00% | 0 shares | 15K | $71.57 | 10K | |
| Q2 2016 | share | 0.00% | 0 shares | 67.9K | $69.79 | 10K | |
| Q1 2016 | share | Decrease | -6.98% | -750 shares | -185.9K | $63.39 | 10K |